Literature DB >> 21472139

Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells.

Peter Ly1, Ugur Eskiocak, Sang B Kim, Andres I Roig, Suzie K Hight, Dypti R Lulla, Ying S Zou, Kimberly Batten, Woodring E Wright, Jerry W Shay.   

Abstract

Chromosomal instability leading to aneuploidy occurs in most sporadic colorectal cancers (CRCs) and is believed to be an early driving force in disease progression. Despite this observation, the cellular advantages conferred by these cytogenetic alterations are poorly understood. Here, we provide evidence that serum-free passage of originally diploid, immortalized human colonic epithelial cells (HCECs) gave rise to the acquisition of trisomy 7 (+7), an aneuploidy detected in more than 40% of colorectal adenomas. These cells remain diploid under long-term growth in 2% serum conditions. Analysis by GTG banding and fluorescent in situ hybridization detected no rare preexisting +7 cell in the original population, suggesting a conversion of diploid cells to an aneuploid state. The acquisition of +7 also precedes loss or truncation of the adenomatosis polyposis coli gene as both diploid and +7 cells express full-length, functional protein. Coculturing of fluorescent-labeled cells demonstrate that +7 HCECs have a growth advantage over diploid cells in serum-free conditions. Defects in cell migration and aberrant regulation of the epidermal growth factor receptor, located on chromosome 7p, are also detected in +7 HCECs. Interestingly, knockdown of TP53 and expression of K-Ras(V12) in +7 HCECs resulted in the emergence of trisomy 20, another nonrandom aneuploidy observed in ∼85% of CRC. In summary, we describe isogenic colonic epithelial cells that represent cytogenetic changes occurring frequently in sporadic CRC. The emergence and characterization of trisomy 7 and 20 demonstrate that these HCECs may serve as unique human cell-based models to examine the effects of chromosomal instability in CRC progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472139      PMCID: PMC3071083          DOI: 10.1593/neo.101580

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  50 in total

Review 1.  The cell surface: the stage for matrix metalloproteinase regulation of migration.

Authors:  Motoharu Seiki
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

Review 2.  Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

Authors:  Siu-Fun Wong
Journal:  Clin Ther       Date:  2005-06       Impact factor: 3.393

3.  Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.

Authors:  Silke Lassmann; Roland Weis; Frank Makowiec; Jasmine Roth; Mihai Danciu; Ulrich Hopt; Martin Werner
Journal:  J Mol Med (Berl)       Date:  2006-12-02       Impact factor: 4.599

Review 4.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

6.  Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.

Authors:  K Aoki; M Aoki; M Sugai; N Harada; H Miyoshi; T Tsukamoto; T Mizoshita; M Tatematsu; H Seno; T Chiba; M Oshima; C-L Hsieh; M M Taketo
Journal:  Oncogene       Date:  2006-12-11       Impact factor: 9.867

7.  Neoplastic transformation of human diploid fibroblasts after long-term serum starvation.

Authors:  Jingyu Zhang; Xia Wang; Yanhong Zhao; Bing Chen; Guangli Suo; Jianwu Dai
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

8.  Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.

Authors:  Madhvi B Upender; Jens K Habermann; Lisa M McShane; Edward L Korn; J Carl Barrett; Michael J Difilippantonio; Thomas Ried
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

9.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

Review 10.  The significance of unstable chromosomes in colorectal cancer.

Authors:  Harith Rajagopalan; Martin A Nowak; Bert Vogelstein; Christoph Lengauer
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

View more
  15 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation.

Authors:  P Ly; S B Kim; A A Kaisani; G Marian; W E Wright; J W Shay
Journal:  Oncogene       Date:  2012-08-13       Impact factor: 9.867

4.  Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways.

Authors:  Pan Cheng; Xin Zhao; Lizabeth Katsnelson; Elaine M Camacho-Hernandez; Angela Mermerian; Joseph C Mays; Scott M Lippman; Reyna Edith Rosales-Alvarez; Raquel Moya; Jasmine Shwetar; Dominic Grun; David Fenyo; Teresa Davoli
Journal:  Elife       Date:  2022-09-21       Impact factor: 8.713

5.  Cancer cells preferentially lose small chromosomes.

Authors:  Pascal H G Duijf; Nikolaus Schultz; Robert Benezra
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

Review 6.  Aneuploidy and gene expression: is there dosage compensation?

Authors:  Shihoko Kojima; Daniela Cimini
Journal:  Epigenomics       Date:  2019-11-22       Impact factor: 4.778

7.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability.

Authors:  James O Patterson; Sally Dewhurst; Laurent Sansregret; Carlos López-García; André Koch; Nicholas McGranahan; William Chong Hang Chao; David J Barry; Andrew Rowan; Rachael Instrell; Stuart Horswell; Michael Way; Michael Howell; Martin R Singleton; René H Medema; Paul Nurse; Mark Petronczki; Charles Swanton
Journal:  Cancer Discov       Date:  2017-01-09       Impact factor: 39.397

9.  Single-nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of Turner syndrome.

Authors:  Siddharth Prakash; Dongchuan Guo; Cheryl L Maslen; Michael Silberbach; Dianna Milewicz; Carolyn A Bondy
Journal:  Genet Med       Date:  2013-06-06       Impact factor: 8.822

10.  Cancer karyotypes: survival of the fittest.

Authors:  Joshua M Nicholson; Daniela Cimini
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.